Determination of serum TSH and free T4 (fT4) by radioimmunoassay have, within the last few years, become the front line general screening tests for thyroid dysfunction.
Thyroid stimulating hormone is normally present in serum at concentrations ranging from undetectable to up to 9 uU/ml and is one of the few protein hormones readily determined by radioimmunoassay in the typical hospital laboratory. For some time, TSH determination has been useful for detecting primary hypothyroidism because results are elevated more markedly and well before thyroid hormone is definitely decreased and frank symptoms of hypothyroidism become apparent. Since functionally active thyroid tissue can secrete thyroid hormone at rates about ten times greater than necessary to maintain normal circulating concentrations, approximately 90 percent of thyroid tissue must be rendered nonfunctional before circulatine thyroid hormone decreases. Because of the negative feedback effect of T4 on TSH secretion, TSH concentrations are expected to increase in direct proportion to the extent of thyroid tissue damage, stimulating remaining functional tissue to maintain normal hormone concentrations until excess functional capacity is exceeded. In practice, the TSH increase is not as marked as expected.
In cases of hypothyroidism secondary to pituitary or hypothalamic insufficiency, TSH concentrations are, of course, decreased.
Hyperthyroidism from hypersecretion of TSH is exceedingly rare so that elevated TSH concentrations are almost never associated with hyperthyroidism. TSH assays, until recently, were insufficiently sensitive to distinguish low normal concentrations from below normal so that diagnosis of hyperthyroidism on the basis of documenting low TSH concentration was not possible. Sufficiently sensitive TSH assays have recently become available and are now in routine use for this purpose.
Return to the list of tests in the main document.
Free thyroxin results more reliably reflect thyroid status than do results from total thyroxin determination. fT4 results are not confounded by abnormal TBG concentrations as are TT4 results. Reliable, sufficiently sensitive imunoassays have recently become available and are now in routine use in most hospital laboratories.
Total thyroxin determination by radioimmunoassay has been a readily available, routine test in most hospital laboratories for the past 20 years and had been the front line, general screening test for thyroid status before the ready availability of free T4 and sensitive TSH tests. Total T4 results adequately reflect thyroid status when TBG concentrations are normal. However, when TBG concentrations are abnormal, results do not correctly reflect thyroid functional status. It had been common practice to conduct a T3 Resin Uptake test (T3RU) as well and to estimate free thyroxin status by calculating the "free thyroxin index" (FTI) from TT4 and T3RU.
How variations in TBG concentration cause TT4 results to incorrectly reflect thyroid status can be understood by considering the binding equilibrium:
The most common abnormalities of TBG concentration involve approximately 2 fold elevations in pregnancy, in women taking oral contraceptives, or in patients on estrogen therapy for whatever reason, as shown in the figure to the right. Estrogens induce increased hepatic synthesis of a variety of circulating transport proteins, including TBG. On the other hand, decreased TBG concentrations are found in patients with severe, chronic liver disease when hepatic protein synthesizing capacity is compromised and in cases with massive protein loss from the nephrotic syndrome. Congenital abnormalities in TBG synthesis have also been reported.
Determination of TBG, along with total T4, would allow calculation of free T4 by equation 4, above, but direct TBG measurements are not available. The T3 uptake test, described below, does, however, provide an estimate of unoccupied TBG sites and is used in practice to "correct" or "normalize" TT4 concentrations for variations in TBG concentration, by equation 2, above, and provides a value (referred to as the Free Thyroxin Index, FTI) which is proportional to the free thyroxin concentration.
Return to the list of tests in the main document.
The principle of the T3 uptake test is illustrated in the figure to the right. The test is conducted by adding a known, excess amount of 125I labeled T3 to a measured volume of serum. The added radiolabeled T3 binds to and saturates the unoccupied TBG sites and does not displace the more tightly bound T4. The excess, unbound 125I T3 is then separated from the serum bound 125I T3 by adding an adsorbent, such as ion exchange resin beads and centrifuging. The serum is decanted, the beads are washed and then counted in a scintillation counter.
Results were interpreted in the past as illustrated in the figure to the right, assuming normal TBG concentrations. Hyperthyroid cases exhibit a decreased concentration of unoccupied TBG sites and an increased T3 resin uptake. Hypothyroid patients have increased unoccupied TBG sites and decreased T3 resin uptake.
Return to the list of tests in the main document.
The free thyroxin index [ FTI; also referred to as the corrected T4 (CT4) or normalized T4 (NT4) ] utilizes results from both the TT4 determination and the T3 uptake test to provide a value which is proportional to the free thyroxin concentration regardless of TBG concentration. As illustrated in the figures above, the serum uptake of T3* (T3*SU) is proportional to the concentration of unsaturated TBG sites. So that according to equation 2, above,
Return to the list of tests in the main document.
Like T4, total circulating T3 was measured by radioimmunoassay using a specific reagent antibody to T3. Total T3 is influenced by TBG concentration in the same manner as T4 and can likewise by "corrected" with results from the T3 uptake test. The major clinical value in measuring T3 concentrations was that T3 is often more markedly elevated than is T4 in hyperthyroidism. With the advent of the sensitive TSH assay providing this information, T3 by RIA is no longer needed.
Return to the list of tests in the main document.
The TRH stimulation test is used to distinguish between pituitary or hypothalamic deficiency as the cause of secondary hypothyroidisme and to evaluate cases of hyperthyroidism. The test is conducted by collecting blood specimens for TSH before and thirty minutes after intravenous administration of a test dose of TRH. The normal response is a substantial increase in TSH in the 30 minute specimen.
Return to the list of tests in the main document.
Graves' disease, Hashimoto's thyroiditis and primary (autoimmune) myxedema all involve the presence of autoantibodies to thyroid tissue. These auto-antibodies may be directed against microsomal components, thyroglobulin, and/or membrane TSH receptors.
Return to the list of tests in the main document.
Functioning thyroid tissue avidly extracts iodide from the circulation. The rate of iodide uptake depends upon functional activity. Between several hours and a day after the administration of a small dose of 131I, the thyroid is autoradiographed. The autoradiograph may exhibit a diffuse or localized (nodular) pattern of uptake. The major clinical value of the radiologic test is in detecting hyper- or hypofunctioning nodules. A localized "hot" (hyperfunctioning) uptake pattern represents a rare cause of hyperthyroidism and results from the presence of an isolated, hyperfunctioning nodule in a multinodular goiter or of an autonomously functioning adenoma. A "cold" (nonfunctioning) nodule suggests the possibility of carcinoma.
Return to the list of tests in the main document.
Keq
TBG + T4 <-----> TBG-T4
Free and bound T4 are related by:
free T4 = (bound T4/unoccupied TBG sites)xKeq (equation 1)
Since greater than 99.9% of total T4 is bound, then bound T4 ~ total T4. Then,
free T4 = (total T4/unoccupied TBG sites)xKeq (equation 2)
Also, since unoccupied TBG sites = total TBG sites - bound T4
or, unoccupied TBG sites ~ total TBG sites - total T4, then
free T4 = [total T4/(total TBG - total T4)]xKeq (equation 3), or
free T4 = [(total T4/TBG)/(1 - total T4/TBG)]xKeq (equation 4)
T3 Resin Uptake
The simpler T3 uptake test was as reliable as the total T4 determination by radioimmunoassay, but is obviously also influenced by variations in TBG concentrations. A euthyroid individual with an elevated TBG concentration would have a low T3 resin uptake and, thus, appear hypothyroid. A euthyroid individual with a low TBG concentration would have a high T3 resin uptake and, thus, appear hyperthyroid, etc. When TBG is abnormal, TT4 and T3RU results indicate opposite conditions. Contrary indications about thyroid status from the two tests, thus, suggest that TBG concentration is abnormal and that each individual result is unreliable.
Free Thyroxin Index (FTI, or CT4 or NT4)
The FTI provided an accurate indication of thyroid status because it is proportional to the free T4 concentration and is not influenced by variations in TBG concentration as are the individual total T4 and T3 resin uptake determinations.
Triiodothyronine (or T3) by RIA
TRH Stimulation Test
In secondary hypothyroidism caused by pituitary insufficiency the TSH concentration in the thirty minute specimen will remain essentially unchanged. The TSH concentration in the thirty minute specimen will be noticeably increased in cases of hypothalamic insufficiency.
In hyperthyroidism, the pituitary is suppressed by elevated thyroid hormone and there is no significant increase in TSH in the 30 minute specimen.
Detection of Thyroid Autoantibodies
Microsomal and thyroglobulin autoantibodies are determined by most hospital laboratories using latex, or red cell, agglutination methods. These autoantibodies are present in almost all cases of Graves', Hashimoto's and primary (autoimmune) myxedema.
Thyroid Scan
Last Updated: March 15, 2000